Cullinan Oncology Management
Management criteria checks 2/4
Cullinan Oncology's CEO is Nadim Ahmed, appointed in Oct 2021, has a tenure of 2.5 years. total yearly compensation is $4.01M, comprised of 16.2% salary and 83.8% bonuses, including company stock and options. directly owns 0.074% of the company’s shares, worth $534.62K. The average tenure of the management team and the board of directors is 2.3 years and 1.1 years respectively.
Key information
Nadim Ahmed
Chief executive officer
US$4.0m
Total compensation
| CEO salary percentage | 16.2% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.07% |
| Management average tenure | 2.3yrs |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
Cullinan Oncology: Modality-Agnostic Approach To Yield Fruit In Coming Years
Sep 22Cullinan Oncology: One Of The Leaders In Cancer Treatment Development
Sep 14Cullinan Oncology grants stock options for 125.7K shares
Sep 02Companies Like Cullinan Oncology (NASDAQ:CGEM) Are In A Position To Invest In Growth
Jun 24
Here's Why We're Not Too Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Situation
Mar 05Companies Like Cullinan Oncology (NASDAQ:CGEM) Are In A Position To Invest In Growth
Oct 08Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
Jun 30Cullinan Oncology (CGEM) Presents At 2021 ASCO Annual Virtual Meeting - Slideshow
Jun 05Cullinan initiated Buy at H.C. Wainwright on pipeline strength
Feb 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$4m | US$649k | -US$153m |
| Sep 30 2023 | n/a | n/a | -US$156m |
| Jun 30 2023 | n/a | n/a | -US$142m |
| Mar 31 2023 | n/a | n/a | US$65m |
| Dec 31 2022 | US$4m | US$618k | US$111m |
| Sep 30 2022 | n/a | n/a | US$105m |
| Jun 30 2022 | n/a | n/a | US$113m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$39m | US$125k | -US$66m |
Compensation vs Market: Nadim's total compensation ($USD4.01M) is about average for companies of similar size in the US market ($USD3.45M).
Compensation vs Earnings: Nadim's compensation has increased whilst the company is unprofitable.
CEO
Nadim Ahmed (55 yo)
2.5yrs
Tenure
US$4,008,206
Compensation
Mr. Nadim Ahmed has been a President, Chief Executive Officer and Director of Cullinan Oncology, Inc. since October 18, 2021. He joined Cullinan Oncology, Inc. in October 2021. He has been Executive Direct...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.01m | 0.074% $ 534.6k | |
| Chief Medical Officer | 2.2yrs | US$2.42m | 0.029% $ 207.4k | |
| Co-Founder | no data | US$1.96m | 0.82% $ 5.9m | |
| Chief Scientific Officer | less than a year | no data | 0.11% $ 754.4k | |
| Chief Legal Officer | 1.7yrs | no data | 0.023% $ 164.4k | |
| Senior Vice President of Communications | 2.3yrs | no data | no data | |
| Chief Human Resources Officer | 2.3yrs | no data | no data | |
| Chief Business Officer | 7.2yrs | no data | 0.33% $ 2.4m | |
| Chief Technical Operations Officer | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
55.5yo
Average Age
Experienced Management: CGEM's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.01m | 0.074% $ 534.6k | |
| Co-Founder | less than a year | US$1.96m | 0.82% $ 5.9m | |
| Independent Director | 6.7yrs | US$220.20k | 0.16% $ 1.1m | |
| Independent Director | 3.6yrs | US$208.92k | 0% $ 0 | |
| Independent Chairman of the Board | 6.7yrs | US$284.84k | 0.10% $ 750.2k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 2.1yrs | US$164.45k | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 1.4yrs | US$256.66k | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
1.1yrs
Average Tenure
62yo
Average Age
Experienced Board: CGEM's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.